SPONSOR
Mario Negri Institute for Pharmacological Research
Total Trials
5
Recruiting
5
Phases
Phase 2
Conditions studied: Emergency MedicineAtypical Hemolytic Uremic SyndromeMembranoproliferative GlomerulonephritisAutosomal Dominant Polycystic KidneyHealthySemi-intensive Care UnitEvaluationQualityMembranous NephropathyCardiac Arrest, Out-Of-Hospital
Mario Negri Institute for Pharmacological Research is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Emergency Medicine, Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, Autosomal Dominant Polycystic Kidney.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Mario Negri Institute for Pharmacological Research
How many clinical trials has Mario Negri Institute for Pharmacological Research sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Mario Negri Institute for Pharmacological Research, of which 5 are actively recruiting participants. These trials cover conditions including Emergency Medicine, Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Mario Negri Institute for Pharmacological Research research focus on?
Mario Negri Institute for Pharmacological Research clinical trials span Emergency Medicine, Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, Autosomal Dominant Polycystic Kidney, Healthy, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Mario Negri Institute for Pharmacological Research clinical trial?
To participate in a Mario Negri Institute for Pharmacological Research trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Mario Negri Institute for Pharmacological Research trials with current recruitment status updated daily.
Clinical Trials by Mario Negri Institute for Pharmacological Research
NCT06354764
Recruiting
Propensity to Hospitalize Patients From the ED in European Centers.
Emergency Medicine
NCT05996731
Recruiting
Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases
Atypical Hemolytic Uremic Syndrome
NCT04676347
Recruiting
Health-care Quality in Semi-intensive Care Units
Semi-intensive Care Unit
NCT04095156
Recruiting
Autoreactive B Cells in Membranous Nephropathy
Membranous Nephropathy
NCT05482945 Phase 2
Recruiting
CardioPulmonary Resuscitation With Argon (CPAr) Trial
Cardiac Arrest, Out-Of-Hospital
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology